カテゴリ： GlobalInfoResearch, 世界, 医療/バイオ

経口利尿薬のグローバル市場2023：ループ利尿薬、チアジド系利尿薬、炭酸脱水酵素阻害薬、カリウム保持性利尿薬、浸透圧利尿薬

■ 英語タイトル：Global Oral Diuretic Drugs Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

調査会社GlobalInfoResearch社が発行したリサーチレポート（データ管理コード：GIR23AG11495）■ 発行会社/調査会社：GlobalInfoResearch
■ 商品コード：GIR23AG11495
■ 発行日：2023年8月
■ 調査対象地域：グローバル
■ 産業分野：医薬品＆ヘルスケア
■ ページ数：107
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（注文後2-3日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,480 ⇒換算￥528,960見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,220 ⇒換算￥793,440見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）USD6,960 ⇒換算￥1,057,920見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※GlobalInfoResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[経口利尿薬のグローバル市場2023：ループ利尿薬、チアジド系利尿薬、炭酸脱水酵素阻害薬、カリウム保持性利尿薬、浸透圧利尿薬]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

Global Info Research社の最新の調査によると、経口利尿薬のグローバル市場規模は2022年のxxx米ドルから2029年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。新型コロナウイルス感染症とロシア・ウクライナ戦争の影響を考慮しながら市場規模を推計しました。
本調査レポートは、世界の経口利尿薬市場に関する詳細かつ包括的な分析の結果です。定量的分析と定性的分析データが、メーカー別、地域別、国別、種類別、用途別に記載されています。

市場は常に変化しているため、本レポートでは、競争、需要と供給の傾向、および多くの市場にわたる需要の変化に影響する主要な要因を調査しました。主要な競合他社の企業概要と製品例、および2023年の市場シェア予測も記載しました。

本資料の主な目的は次のとおりです。
- 世界および主要国の市場機会の規模を決定するため
- 経口利尿薬の成長可能性を評価するため
- 各製品および最終用途市場の将来の成長を予測するため
- 市場に影響を与える競争要因を評価するため

経口利尿薬市場は種類と用途によって区分されます。2018年～2029年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

種類別セグメント
・ループ利尿薬、チアジド系利尿薬、炭酸脱水酵素阻害薬、カリウム保持性利尿薬、浸透圧利尿薬

用途別セグメント
・病院薬局、小売薬局、オンライン薬局

主要な市場プレーヤー
・AstraZeneca、Aurobindo Pharma、Bayer AG、Bristol-Myers Squibb Company、Cipla Ltd、F. Hoffmann-La Roche、Fresenius Kabi、GSK、Hikma Pharmaceuticals、Mylan、Novartis Pharmaceuticals、Pfizer、Sanofi、Teva Pharmaceutical Industries

地域別セグメントは次の地域・国をカバーします。
・北米（アメリカ、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）

本調査レポートの内容は計15章あります。
・第1章では、経口利尿薬製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要な経口利尿薬メーカーの企業概要、2019年～2022年までの経口利尿薬の価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要な経口利尿薬メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2018年～2029年までの地域別経口利尿薬の販売量、売上、成長性を示しています。
・第5、6章では、2018年～2029年までの経口利尿薬の種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2018年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2029年までの主要地域での経口利尿薬市場予測を収録しています。
・第12章では、市場力学、成長要因、阻害要因、トレンド、ポーターズファイブフォース分析、新型コロナウイルス感染症とロシア・ウクライナ戦争の影響を掲載しています。
・第13章では、主要な原材料、主要なサプライヤー、および経口利尿薬の産業チェーンを掲載しています。
・第14、15章では、経口利尿薬の販売チャネル、販売業者、顧客、調査結果について説明します。

・市場概要
– 経口利尿薬の概要
– 種類別分析（2018年vs2022年vs2029年）：ループ利尿薬、チアジド系利尿薬、炭酸脱水酵素阻害薬、カリウム保持性利尿薬、浸透圧利尿薬
– 用途別分析（2018年vs2022年vs2029年）：病院薬局、小売薬局、オンライン薬局
– 世界の経口利尿薬市場規模・予測
– 世界の経口利尿薬生産能力分析
– 市場の成長要因・阻害要因・動向
・メーカー情報（企業概要、製品概要、販売量、価格、売上）
– AstraZeneca、Aurobindo Pharma、Bayer AG、Bristol-Myers Squibb Company、Cipla Ltd、F. Hoffmann-La Roche、Fresenius Kabi、GSK、Hikma Pharmaceuticals、Mylan、Novartis Pharmaceuticals、Pfizer、Sanofi、Teva Pharmaceutical Industries
・メーカー別市場シェア・市場集中度
・地域別市場分析2018年-2029年
・種類別分析2018年-2029年：ループ利尿薬、チアジド系利尿薬、炭酸脱水酵素阻害薬、カリウム保持性利尿薬、浸透圧利尿薬
・用途別分析2018年-2029年：病院薬局、小売薬局、オンライン薬局
・経口利尿薬の北米市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：アメリカ、カナダ、メキシコなど
・経口利尿薬のヨーロッパ市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど
・経口利尿薬のアジア市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど
・経口利尿薬の南米市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：ブラジル、アルゼンチンなど
・経口利尿薬の中東・アフリカ市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど
・市場力学（成長要因、阻害要因、トレンド、ポーターズファイブフォース分析）
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

世界の市場調査レポート販売サイト（H&Iグローバルリサーチ株式会社運営）
*** レポート目次（コンテンツ）***

1 Market Overview
1.1 Product Overview and Scope of Oral Diuretic Drugs
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Oral Diuretic Drugs Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Loop Diuretics
1.3.3 Thiazides and Thiazide-Like Diuretics
1.3.4 Carbonic Anhydrase Inhibitors
1.3.5 Potassium-Sparing Diuretics
1.3.6 Osmotic Diuretics
1.4 Market Analysis by Application
1.4.1 Overview: Global Oral Diuretic Drugs Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Hospital Pharmacies
1.4.3 Retail Pharmacies
1.4.4 Online Pharmacies
1.5 Global Oral Diuretic Drugs Market Size & Forecast
1.5.1 Global Oral Diuretic Drugs Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Oral Diuretic Drugs Sales Quantity (2018-2029)
1.5.3 Global Oral Diuretic Drugs Average Price (2018-2029)
2 Manufacturers Profiles
2.1 AstraZeneca
2.1.1 AstraZeneca Details
2.1.2 AstraZeneca Major Business
2.1.3 AstraZeneca Oral Diuretic Drugs Product and Services
2.1.4 AstraZeneca Oral Diuretic Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 AstraZeneca Recent Developments/Updates
2.2 Aurobindo Pharma
2.2.1 Aurobindo Pharma Details
2.2.2 Aurobindo Pharma Major Business
2.2.3 Aurobindo Pharma Oral Diuretic Drugs Product and Services
2.2.4 Aurobindo Pharma Oral Diuretic Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Aurobindo Pharma Recent Developments/Updates
2.3 Bayer AG
2.3.1 Bayer AG Details
2.3.2 Bayer AG Major Business
2.3.3 Bayer AG Oral Diuretic Drugs Product and Services
2.3.4 Bayer AG Oral Diuretic Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Bayer AG Recent Developments/Updates
2.4 Bristol-Myers Squibb Company
2.4.1 Bristol-Myers Squibb Company Details
2.4.2 Bristol-Myers Squibb Company Major Business
2.4.3 Bristol-Myers Squibb Company Oral Diuretic Drugs Product and Services
2.4.4 Bristol-Myers Squibb Company Oral Diuretic Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Bristol-Myers Squibb Company Recent Developments/Updates
2.5 Cipla Ltd
2.5.1 Cipla Ltd Details
2.5.2 Cipla Ltd Major Business
2.5.3 Cipla Ltd Oral Diuretic Drugs Product and Services
2.5.4 Cipla Ltd Oral Diuretic Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Cipla Ltd Recent Developments/Updates
2.6 F. Hoffmann-La Roche
2.6.1 F. Hoffmann-La Roche Details
2.6.2 F. Hoffmann-La Roche Major Business
2.6.3 F. Hoffmann-La Roche Oral Diuretic Drugs Product and Services
2.6.4 F. Hoffmann-La Roche Oral Diuretic Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 F. Hoffmann-La Roche Recent Developments/Updates
2.7 Fresenius Kabi
2.7.1 Fresenius Kabi Details
2.7.2 Fresenius Kabi Major Business
2.7.3 Fresenius Kabi Oral Diuretic Drugs Product and Services
2.7.4 Fresenius Kabi Oral Diuretic Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Fresenius Kabi Recent Developments/Updates
2.8 GSK
2.8.1 GSK Details
2.8.2 GSK Major Business
2.8.3 GSK Oral Diuretic Drugs Product and Services
2.8.4 GSK Oral Diuretic Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 GSK Recent Developments/Updates
2.9 Hikma Pharmaceuticals
2.9.1 Hikma Pharmaceuticals Details
2.9.2 Hikma Pharmaceuticals Major Business
2.9.3 Hikma Pharmaceuticals Oral Diuretic Drugs Product and Services
2.9.4 Hikma Pharmaceuticals Oral Diuretic Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Hikma Pharmaceuticals Recent Developments/Updates
2.10 Mylan
2.10.1 Mylan Details
2.10.2 Mylan Major Business
2.10.3 Mylan Oral Diuretic Drugs Product and Services
2.10.4 Mylan Oral Diuretic Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Mylan Recent Developments/Updates
2.11 Novartis Pharmaceuticals
2.11.1 Novartis Pharmaceuticals Details
2.11.2 Novartis Pharmaceuticals Major Business
2.11.3 Novartis Pharmaceuticals Oral Diuretic Drugs Product and Services
2.11.4 Novartis Pharmaceuticals Oral Diuretic Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Novartis Pharmaceuticals Recent Developments/Updates
2.12 Pfizer
2.12.1 Pfizer Details
2.12.2 Pfizer Major Business
2.12.3 Pfizer Oral Diuretic Drugs Product and Services
2.12.4 Pfizer Oral Diuretic Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 Pfizer Recent Developments/Updates
2.13 Sanofi
2.13.1 Sanofi Details
2.13.2 Sanofi Major Business
2.13.3 Sanofi Oral Diuretic Drugs Product and Services
2.13.4 Sanofi Oral Diuretic Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 Sanofi Recent Developments/Updates
2.14 Teva Pharmaceutical Industries
2.14.1 Teva Pharmaceutical Industries Details
2.14.2 Teva Pharmaceutical Industries Major Business
2.14.3 Teva Pharmaceutical Industries Oral Diuretic Drugs Product and Services
2.14.4 Teva Pharmaceutical Industries Oral Diuretic Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.14.5 Teva Pharmaceutical Industries Recent Developments/Updates
3 Competitive Environment: Oral Diuretic Drugs by Manufacturer
3.1 Global Oral Diuretic Drugs Sales Quantity by Manufacturer (2018-2023)
3.2 Global Oral Diuretic Drugs Revenue by Manufacturer (2018-2023)
3.3 Global Oral Diuretic Drugs Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Oral Diuretic Drugs by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Oral Diuretic Drugs Manufacturer Market Share in 2022
3.4.2 Top 6 Oral Diuretic Drugs Manufacturer Market Share in 2022
3.5 Oral Diuretic Drugs Market: Overall Company Footprint Analysis
3.5.1 Oral Diuretic Drugs Market: Region Footprint
3.5.2 Oral Diuretic Drugs Market: Company Product Type Footprint
3.5.3 Oral Diuretic Drugs Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Oral Diuretic Drugs Market Size by Region
4.1.1 Global Oral Diuretic Drugs Sales Quantity by Region (2018-2029)
4.1.2 Global Oral Diuretic Drugs Consumption Value by Region (2018-2029)
4.1.3 Global Oral Diuretic Drugs Average Price by Region (2018-2029)
4.2 North America Oral Diuretic Drugs Consumption Value (2018-2029)
4.3 Europe Oral Diuretic Drugs Consumption Value (2018-2029)
4.4 Asia-Pacific Oral Diuretic Drugs Consumption Value (2018-2029)
4.5 South America Oral Diuretic Drugs Consumption Value (2018-2029)
4.6 Middle East and Africa Oral Diuretic Drugs Consumption Value (2018-2029)
5 Market Segment by Type
5.1 Global Oral Diuretic Drugs Sales Quantity by Type (2018-2029)
5.2 Global Oral Diuretic Drugs Consumption Value by Type (2018-2029)
5.3 Global Oral Diuretic Drugs Average Price by Type (2018-2029)
6 Market Segment by Application
6.1 Global Oral Diuretic Drugs Sales Quantity by Application (2018-2029)
6.2 Global Oral Diuretic Drugs Consumption Value by Application (2018-2029)
6.3 Global Oral Diuretic Drugs Average Price by Application (2018-2029)
7 North America
7.1 North America Oral Diuretic Drugs Sales Quantity by Type (2018-2029)
7.2 North America Oral Diuretic Drugs Sales Quantity by Application (2018-2029)
7.3 North America Oral Diuretic Drugs Market Size by Country
7.3.1 North America Oral Diuretic Drugs Sales Quantity by Country (2018-2029)
7.3.2 North America Oral Diuretic Drugs Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
8.1 Europe Oral Diuretic Drugs Sales Quantity by Type (2018-2029)
8.2 Europe Oral Diuretic Drugs Sales Quantity by Application (2018-2029)
8.3 Europe Oral Diuretic Drugs Market Size by Country
8.3.1 Europe Oral Diuretic Drugs Sales Quantity by Country (2018-2029)
8.3.2 Europe Oral Diuretic Drugs Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
9.1 Asia-Pacific Oral Diuretic Drugs Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Oral Diuretic Drugs Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Oral Diuretic Drugs Market Size by Region
9.3.1 Asia-Pacific Oral Diuretic Drugs Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Oral Diuretic Drugs Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
10.1 South America Oral Diuretic Drugs Sales Quantity by Type (2018-2029)
10.2 South America Oral Diuretic Drugs Sales Quantity by Application (2018-2029)
10.3 South America Oral Diuretic Drugs Market Size by Country
10.3.1 South America Oral Diuretic Drugs Sales Quantity by Country (2018-2029)
10.3.2 South America Oral Diuretic Drugs Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
11.1 Middle East & Africa Oral Diuretic Drugs Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Oral Diuretic Drugs Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Oral Diuretic Drugs Market Size by Country
11.3.1 Middle East & Africa Oral Diuretic Drugs Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Oral Diuretic Drugs Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
12.1 Oral Diuretic Drugs Market Drivers
12.2 Oral Diuretic Drugs Market Restraints
12.3 Oral Diuretic Drugs Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
13.1 Raw Material of Oral Diuretic Drugs and Key Manufacturers
13.2 Manufacturing Costs Percentage of Oral Diuretic Drugs
13.3 Oral Diuretic Drugs Production Process
13.4 Oral Diuretic Drugs Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Oral Diuretic Drugs Typical Distributors
14.3 Oral Diuretic Drugs Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer

List of Tables
Table 1. Global Oral Diuretic Drugs Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Oral Diuretic Drugs Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 4. AstraZeneca Major Business
Table 5. AstraZeneca Oral Diuretic Drugs Product and Services
Table 6. AstraZeneca Oral Diuretic Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. AstraZeneca Recent Developments/Updates
Table 8. Aurobindo Pharma Basic Information, Manufacturing Base and Competitors
Table 9. Aurobindo Pharma Major Business
Table 10. Aurobindo Pharma Oral Diuretic Drugs Product and Services
Table 11. Aurobindo Pharma Oral Diuretic Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Aurobindo Pharma Recent Developments/Updates
Table 13. Bayer AG Basic Information, Manufacturing Base and Competitors
Table 14. Bayer AG Major Business
Table 15. Bayer AG Oral Diuretic Drugs Product and Services
Table 16. Bayer AG Oral Diuretic Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. Bayer AG Recent Developments/Updates
Table 18. Bristol-Myers Squibb Company Basic Information, Manufacturing Base and Competitors
Table 19. Bristol-Myers Squibb Company Major Business
Table 20. Bristol-Myers Squibb Company Oral Diuretic Drugs Product and Services
Table 21. Bristol-Myers Squibb Company Oral Diuretic Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Bristol-Myers Squibb Company Recent Developments/Updates
Table 23. Cipla Ltd Basic Information, Manufacturing Base and Competitors
Table 24. Cipla Ltd Major Business
Table 25. Cipla Ltd Oral Diuretic Drugs Product and Services
Table 26. Cipla Ltd Oral Diuretic Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. Cipla Ltd Recent Developments/Updates
Table 28. F. Hoffmann-La Roche Basic Information, Manufacturing Base and Competitors
Table 29. F. Hoffmann-La Roche Major Business
Table 30. F. Hoffmann-La Roche Oral Diuretic Drugs Product and Services
Table 31. F. Hoffmann-La Roche Oral Diuretic Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. F. Hoffmann-La Roche Recent Developments/Updates
Table 33. Fresenius Kabi Basic Information, Manufacturing Base and Competitors
Table 34. Fresenius Kabi Major Business
Table 35. Fresenius Kabi Oral Diuretic Drugs Product and Services
Table 36. Fresenius Kabi Oral Diuretic Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. Fresenius Kabi Recent Developments/Updates
Table 38. GSK Basic Information, Manufacturing Base and Competitors
Table 39. GSK Major Business
Table 40. GSK Oral Diuretic Drugs Product and Services
Table 41. GSK Oral Diuretic Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. GSK Recent Developments/Updates
Table 43. Hikma Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 44. Hikma Pharmaceuticals Major Business
Table 45. Hikma Pharmaceuticals Oral Diuretic Drugs Product and Services
Table 46. Hikma Pharmaceuticals Oral Diuretic Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. Hikma Pharmaceuticals Recent Developments/Updates
Table 48. Mylan Basic Information, Manufacturing Base and Competitors
Table 49. Mylan Major Business
Table 50. Mylan Oral Diuretic Drugs Product and Services
Table 51. Mylan Oral Diuretic Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 52. Mylan Recent Developments/Updates
Table 53. Novartis Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 54. Novartis Pharmaceuticals Major Business
Table 55. Novartis Pharmaceuticals Oral Diuretic Drugs Product and Services
Table 56. Novartis Pharmaceuticals Oral Diuretic Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 57. Novartis Pharmaceuticals Recent Developments/Updates
Table 58. Pfizer Basic Information, Manufacturing Base and Competitors
Table 59. Pfizer Major Business
Table 60. Pfizer Oral Diuretic Drugs Product and Services
Table 61. Pfizer Oral Diuretic Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 62. Pfizer Recent Developments/Updates
Table 63. Sanofi Basic Information, Manufacturing Base and Competitors
Table 64. Sanofi Major Business
Table 65. Sanofi Oral Diuretic Drugs Product and Services
Table 66. Sanofi Oral Diuretic Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 67. Sanofi Recent Developments/Updates
Table 68. Teva Pharmaceutical Industries Basic Information, Manufacturing Base and Competitors
Table 69. Teva Pharmaceutical Industries Major Business
Table 70. Teva Pharmaceutical Industries Oral Diuretic Drugs Product and Services
Table 71. Teva Pharmaceutical Industries Oral Diuretic Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 72. Teva Pharmaceutical Industries Recent Developments/Updates
Table 73. Global Oral Diuretic Drugs Sales Quantity by Manufacturer (2018-2023) & (K Units)
Table 74. Global Oral Diuretic Drugs Revenue by Manufacturer (2018-2023) & (USD Million)
Table 75. Global Oral Diuretic Drugs Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 76. Market Position of Manufacturers in Oral Diuretic Drugs, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 77. Head Office and Oral Diuretic Drugs Production Site of Key Manufacturer
Table 78. Oral Diuretic Drugs Market: Company Product Type Footprint
Table 79. Oral Diuretic Drugs Market: Company Product Application Footprint
Table 80. Oral Diuretic Drugs New Market Entrants and Barriers to Market Entry
Table 81. Oral Diuretic Drugs Mergers, Acquisition, Agreements, and Collaborations
Table 82. Global Oral Diuretic Drugs Sales Quantity by Region (2018-2023) & (K Units)
Table 83. Global Oral Diuretic Drugs Sales Quantity by Region (2024-2029) & (K Units)
Table 84. Global Oral Diuretic Drugs Consumption Value by Region (2018-2023) & (USD Million)
Table 85. Global Oral Diuretic Drugs Consumption Value by Region (2024-2029) & (USD Million)
Table 86. Global Oral Diuretic Drugs Average Price by Region (2018-2023) & (US$/Unit)
Table 87. Global Oral Diuretic Drugs Average Price by Region (2024-2029) & (US$/Unit)
Table 88. Global Oral Diuretic Drugs Sales Quantity by Type (2018-2023) & (K Units)
Table 89. Global Oral Diuretic Drugs Sales Quantity by Type (2024-2029) & (K Units)
Table 90. Global Oral Diuretic Drugs Consumption Value by Type (2018-2023) & (USD Million)
Table 91. Global Oral Diuretic Drugs Consumption Value by Type (2024-2029) & (USD Million)
Table 92. Global Oral Diuretic Drugs Average Price by Type (2018-2023) & (US$/Unit)
Table 93. Global Oral Diuretic Drugs Average Price by Type (2024-2029) & (US$/Unit)
Table 94. Global Oral Diuretic Drugs Sales Quantity by Application (2018-2023) & (K Units)
Table 95. Global Oral Diuretic Drugs Sales Quantity by Application (2024-2029) & (K Units)
Table 96. Global Oral Diuretic Drugs Consumption Value by Application (2018-2023) & (USD Million)
Table 97. Global Oral Diuretic Drugs Consumption Value by Application (2024-2029) & (USD Million)
Table 98. Global Oral Diuretic Drugs Average Price by Application (2018-2023) & (US$/Unit)
Table 99. Global Oral Diuretic Drugs Average Price by Application (2024-2029) & (US$/Unit)
Table 100. North America Oral Diuretic Drugs Sales Quantity by Type (2018-2023) & (K Units)
Table 101. North America Oral Diuretic Drugs Sales Quantity by Type (2024-2029) & (K Units)
Table 102. North America Oral Diuretic Drugs Sales Quantity by Application (2018-2023) & (K Units)
Table 103. North America Oral Diuretic Drugs Sales Quantity by Application (2024-2029) & (K Units)
Table 104. North America Oral Diuretic Drugs Sales Quantity by Country (2018-2023) & (K Units)
Table 105. North America Oral Diuretic Drugs Sales Quantity by Country (2024-2029) & (K Units)
Table 106. North America Oral Diuretic Drugs Consumption Value by Country (2018-2023) & (USD Million)
Table 107. North America Oral Diuretic Drugs Consumption Value by Country (2024-2029) & (USD Million)
Table 108. Europe Oral Diuretic Drugs Sales Quantity by Type (2018-2023) & (K Units)
Table 109. Europe Oral Diuretic Drugs Sales Quantity by Type (2024-2029) & (K Units)
Table 110. Europe Oral Diuretic Drugs Sales Quantity by Application (2018-2023) & (K Units)
Table 111. Europe Oral Diuretic Drugs Sales Quantity by Application (2024-2029) & (K Units)
Table 112. Europe Oral Diuretic Drugs Sales Quantity by Country (2018-2023) & (K Units)
Table 113. Europe Oral Diuretic Drugs Sales Quantity by Country (2024-2029) & (K Units)
Table 114. Europe Oral Diuretic Drugs Consumption Value by Country (2018-2023) & (USD Million)
Table 115. Europe Oral Diuretic Drugs Consumption Value by Country (2024-2029) & (USD Million)
Table 116. Asia-Pacific Oral Diuretic Drugs Sales Quantity by Type (2018-2023) & (K Units)
Table 117. Asia-Pacific Oral Diuretic Drugs Sales Quantity by Type (2024-2029) & (K Units)
Table 118. Asia-Pacific Oral Diuretic Drugs Sales Quantity by Application (2018-2023) & (K Units)
Table 119. Asia-Pacific Oral Diuretic Drugs Sales Quantity by Application (2024-2029) & (K Units)
Table 120. Asia-Pacific Oral Diuretic Drugs Sales Quantity by Region (2018-2023) & (K Units)
Table 121. Asia-Pacific Oral Diuretic Drugs Sales Quantity by Region (2024-2029) & (K Units)
Table 122. Asia-Pacific Oral Diuretic Drugs Consumption Value by Region (2018-2023) & (USD Million)
Table 123. Asia-Pacific Oral Diuretic Drugs Consumption Value by Region (2024-2029) & (USD Million)
Table 124. South America Oral Diuretic Drugs Sales Quantity by Type (2018-2023) & (K Units)
Table 125. South America Oral Diuretic Drugs Sales Quantity by Type (2024-2029) & (K Units)
Table 126. South America Oral Diuretic Drugs Sales Quantity by Application (2018-2023) & (K Units)
Table 127. South America Oral Diuretic Drugs Sales Quantity by Application (2024-2029) & (K Units)
Table 128. South America Oral Diuretic Drugs Sales Quantity by Country (2018-2023) & (K Units)
Table 129. South America Oral Diuretic Drugs Sales Quantity by Country (2024-2029) & (K Units)
Table 130. South America Oral Diuretic Drugs Consumption Value by Country (2018-2023) & (USD Million)
Table 131. South America Oral Diuretic Drugs Consumption Value by Country (2024-2029) & (USD Million)
Table 132. Middle East & Africa Oral Diuretic Drugs Sales Quantity by Type (2018-2023) & (K Units)
Table 133. Middle East & Africa Oral Diuretic Drugs Sales Quantity by Type (2024-2029) & (K Units)
Table 134. Middle East & Africa Oral Diuretic Drugs Sales Quantity by Application (2018-2023) & (K Units)
Table 135. Middle East & Africa Oral Diuretic Drugs Sales Quantity by Application (2024-2029) & (K Units)
Table 136. Middle East & Africa Oral Diuretic Drugs Sales Quantity by Region (2018-2023) & (K Units)
Table 137. Middle East & Africa Oral Diuretic Drugs Sales Quantity by Region (2024-2029) & (K Units)
Table 138. Middle East & Africa Oral Diuretic Drugs Consumption Value by Region (2018-2023) & (USD Million)
Table 139. Middle East & Africa Oral Diuretic Drugs Consumption Value by Region (2024-2029) & (USD Million)
Table 140. Oral Diuretic Drugs Raw Material
Table 141. Key Manufacturers of Oral Diuretic Drugs Raw Materials
Table 142. Oral Diuretic Drugs Typical Distributors
Table 143. Oral Diuretic Drugs Typical Customers
List of Figures
Figure 1. Oral Diuretic Drugs Picture
Figure 2. Global Oral Diuretic Drugs Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Oral Diuretic Drugs Consumption Value Market Share by Type in 2022
Figure 4. Loop Diuretics Examples
Figure 5. Thiazides and Thiazide-Like Diuretics Examples
Figure 6. Carbonic Anhydrase Inhibitors Examples
Figure 7. Potassium-Sparing Diuretics Examples
Figure 8. Osmotic Diuretics Examples
Figure 9. Global Oral Diuretic Drugs Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 10. Global Oral Diuretic Drugs Consumption Value Market Share by Application in 2022
Figure 11. Hospital Pharmacies Examples
Figure 12. Retail Pharmacies Examples
Figure 13. Online Pharmacies Examples
Figure 14. Global Oral Diuretic Drugs Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 15. Global Oral Diuretic Drugs Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 16. Global Oral Diuretic Drugs Sales Quantity (2018-2029) & (K Units)
Figure 17. Global Oral Diuretic Drugs Average Price (2018-2029) & (US$/Unit)
Figure 18. Global Oral Diuretic Drugs Sales Quantity Market Share by Manufacturer in 2022
Figure 19. Global Oral Diuretic Drugs Consumption Value Market Share by Manufacturer in 2022
Figure 20. Producer Shipments of Oral Diuretic Drugs by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 21. Top 3 Oral Diuretic Drugs Manufacturer (Consumption Value) Market Share in 2022
Figure 22. Top 6 Oral Diuretic Drugs Manufacturer (Consumption Value) Market Share in 2022
Figure 23. Global Oral Diuretic Drugs Sales Quantity Market Share by Region (2018-2029)
Figure 24. Global Oral Diuretic Drugs Consumption Value Market Share by Region (2018-2029)
Figure 25. North America Oral Diuretic Drugs Consumption Value (2018-2029) & (USD Million)
Figure 26. Europe Oral Diuretic Drugs Consumption Value (2018-2029) & (USD Million)
Figure 27. Asia-Pacific Oral Diuretic Drugs Consumption Value (2018-2029) & (USD Million)
Figure 28. South America Oral Diuretic Drugs Consumption Value (2018-2029) & (USD Million)
Figure 29. Middle East & Africa Oral Diuretic Drugs Consumption Value (2018-2029) & (USD Million)
Figure 30. Global Oral Diuretic Drugs Sales Quantity Market Share by Type (2018-2029)
Figure 31. Global Oral Diuretic Drugs Consumption Value Market Share by Type (2018-2029)
Figure 32. Global Oral Diuretic Drugs Average Price by Type (2018-2029) & (US$/Unit)
Figure 33. Global Oral Diuretic Drugs Sales Quantity Market Share by Application (2018-2029)
Figure 34. Global Oral Diuretic Drugs Consumption Value Market Share by Application (2018-2029)
Figure 35. Global Oral Diuretic Drugs Average Price by Application (2018-2029) & (US$/Unit)
Figure 36. North America Oral Diuretic Drugs Sales Quantity Market Share by Type (2018-2029)
Figure 37. North America Oral Diuretic Drugs Sales Quantity Market Share by Application (2018-2029)
Figure 38. North America Oral Diuretic Drugs Sales Quantity Market Share by Country (2018-2029)
Figure 39. North America Oral Diuretic Drugs Consumption Value Market Share by Country (2018-2029)
Figure 40. United States Oral Diuretic Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 41. Canada Oral Diuretic Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 42. Mexico Oral Diuretic Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 43. Europe Oral Diuretic Drugs Sales Quantity Market Share by Type (2018-2029)
Figure 44. Europe Oral Diuretic Drugs Sales Quantity Market Share by Application (2018-2029)
Figure 45. Europe Oral Diuretic Drugs Sales Quantity Market Share by Country (2018-2029)
Figure 46. Europe Oral Diuretic Drugs Consumption Value Market Share by Country (2018-2029)
Figure 47. Germany Oral Diuretic Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. France Oral Diuretic Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. United Kingdom Oral Diuretic Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 50. Russia Oral Diuretic Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 51. Italy Oral Diuretic Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 52. Asia-Pacific Oral Diuretic Drugs Sales Quantity Market Share by Type (2018-2029)
Figure 53. Asia-Pacific Oral Diuretic Drugs Sales Quantity Market Share by Application (2018-2029)
Figure 54. Asia-Pacific Oral Diuretic Drugs Sales Quantity Market Share by Region (2018-2029)
Figure 55. Asia-Pacific Oral Diuretic Drugs Consumption Value Market Share by Region (2018-2029)
Figure 56. China Oral Diuretic Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. Japan Oral Diuretic Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. Korea Oral Diuretic Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. India Oral Diuretic Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 60. Southeast Asia Oral Diuretic Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 61. Australia Oral Diuretic Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 62. South America Oral Diuretic Drugs Sales Quantity Market Share by Type (2018-2029)
Figure 63. South America Oral Diuretic Drugs Sales Quantity Market Share by Application (2018-2029)
Figure 64. South America Oral Diuretic Drugs Sales Quantity Market Share by Country (2018-2029)
Figure 65. South America Oral Diuretic Drugs Consumption Value Market Share by Country (2018-2029)
Figure 66. Brazil Oral Diuretic Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 67. Argentina Oral Diuretic Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 68. Middle East & Africa Oral Diuretic Drugs Sales Quantity Market Share by Type (2018-2029)
Figure 69. Middle East & Africa Oral Diuretic Drugs Sales Quantity Market Share by Application (2018-2029)
Figure 70. Middle East & Africa Oral Diuretic Drugs Sales Quantity Market Share by Region (2018-2029)
Figure 71. Middle East & Africa Oral Diuretic Drugs Consumption Value Market Share by Region (2018-2029)
Figure 72. Turkey Oral Diuretic Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 73. Egypt Oral Diuretic Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 74. Saudi Arabia Oral Diuretic Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 75. South Africa Oral Diuretic Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 76. Oral Diuretic Drugs Market Drivers
Figure 77. Oral Diuretic Drugs Market Restraints
Figure 78. Oral Diuretic Drugs Market Trends
Figure 79. Porters Five Forces Analysis
Figure 80. Manufacturing Cost Structure Analysis of Oral Diuretic Drugs in 2022
Figure 81. Manufacturing Process Analysis of Oral Diuretic Drugs
Figure 82. Oral Diuretic Drugs Industrial Chain
Figure 83. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 84. Direct Channel Pros & Cons
Figure 85. Indirect Channel Pros & Cons
Figure 86. Methodology
Figure 87. Research Process and Data Source


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 緑内障治療薬のグローバル市場：プロスタグランジンアナログ、β遮断薬、αアドレナリン作動薬、炭酸脱水酵素阻害薬、配合剤、その他
  • CNS経口薬のグローバル市場2023：抗うつ薬、抗精神病薬、抗認知症薬、抗パーキンソン病薬、抗てんかん薬、その他
  • メトトレキサート経口液薬剤のグローバル市場展望 2023年-2029年：2.5mg/ml、2mg/ml
  • メルカプトプリン経口液剤のグローバル市場展望 2023年-2029年：20mg/ml、5mg/ml
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(GIR23AG11495 )"経口利尿薬のグローバル市場2023：ループ利尿薬、チアジド系利尿薬、炭酸脱水酵素阻害薬、カリウム保持性利尿薬、浸透圧利尿薬" (英文：Global Oral Diuretic Drugs Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029)はGlobalInfoResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。